BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3341785)

  • 41. [Results of various treatments on the malignant pleural effusion of breast cancer (author's transl)].
    Ohkawa T; Tazaki E
    Rinsho Hoshasen; 1979; 24(10):1041-50. PubMed ID: 502055
    [No Abstract]   [Full Text] [Related]  

  • 42. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
    Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
    Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of malignant pleural effusion secondary to breast cancer: talc pleurodesis and pleuroperitoneal shunting.
    Saute M
    Isr J Med Sci; 1995; 31(2-3):160-2. PubMed ID: 7744586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemorrhagic pleural effusion in Nigerians.
    Onadeko BO
    Trop Geogr Med; 1979 Mar; 31(1):57-61. PubMed ID: 483372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
    Furue H
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peritoneal cytology in the surgical evaluation of gastric carcinoma.
    Hayes N; Wayman J; Wadehra V; Scott DJ; Raimes SA; Griffin SM
    Br J Cancer; 1999 Feb; 79(3-4):520-4. PubMed ID: 10027323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of intracavitary administration of an anticancer agent with glucocorticoid on cancer patients complicated with malignant effusion].
    Takahashi M; Yoshida K; Ikeuchi H; Kano K; Machida T; Miura Y; Takahashi M; Takeda T; Yamada S
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):881-8. PubMed ID: 6413625
    [No Abstract]   [Full Text] [Related]  

  • 49. Palliative treatment of malignant pleural effusions by video-assisted thoracoscopic surgery.
    Benkó I; Molnár TF; Horváth OP
    Acta Chir Hung; 1999; 38(2):131-3. PubMed ID: 10596313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
    Chella A; Ribechini A; Dini P; Adamo C; Mussi A; Angeletti CA
    Minerva Chir; 1994 Nov; 49(11):1077-82. PubMed ID: 7708227
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New approaches in the diagnostic procedure of malignant pleural effusions.
    Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
    Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Intrapleural chemotherapy with cisplatin and adriamycin in lung cancer with carcinomatous pleuritis].
    Fujii M; Kiura K; Okabe K; Toki H
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3203-6. PubMed ID: 3777957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Detection of gastric cancer associated antigens in ascitic and pleural fluid for ascertaining the nature of the exudate].
    Zhang JR; Zhang XY; Chen XT
    Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):729-30, 768. PubMed ID: 2636090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis].
    Yoshino S; Oka M; Hazama S; Suzuki T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1588-91. PubMed ID: 2389953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased glucose concentration in malignant pleural effusions.
    Berger HW; Maher G
    Am Rev Respir Dis; 1971 Mar; 103(3):427-9. PubMed ID: 5152727
    [No Abstract]   [Full Text] [Related]  

  • 57. [Results of therapeutic use of ledakrin in cancer-induced pleural effusion].
    Krawczyk K; Pawlicki M
    Pneumonol Pol; 1979 Sep; 47(9):635-8. PubMed ID: 530860
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of malignant pleural effusions with intracavitary Corynebacterium parvum.
    Casali A; Gionfra T; Rinaldi M; Tonachella R; Tropea F; Venturo I; De Martino C; Curcio CG
    Cancer; 1988 Aug; 62(4):806-11. PubMed ID: 3293763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Massive pleural effusion: malignant and nonmalignant causes in 46 patients.
    Maher GG; Berger HW
    Am Rev Respir Dis; 1972 Mar; 105(3):458-60. PubMed ID: 4501503
    [No Abstract]   [Full Text] [Related]  

  • 60. [Surgical treatment for advanced lung cancer with pleural effusion (author's transl)].
    Iwa T; Watanabe Y; Komori Y; Sato H; Tatsumura T
    Kyobu Geka; 1977; 30(8):656-62. PubMed ID: 904119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.